Noticias de RCUS_US
Noticias del mercado
Últimas noticias sobre RCUS_US — 208 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Arcus to Supply Experimental Kidney Cancer Drug for Myers Squibb Trial
New drug combo from Arcus and BMS targets advanced kidney cancer
Arcus Biosciences Drops 6.0% Amid Sector-Wide Selling
Arcus Biosciences chief accounting officer sells $66,023 in stock By Investing.com
Arcus Biosciences chief accounting officer sells $66,023 in stock By Investing.com
Arcus Biosciences chief accounting officer sells $66,023 in stock By Investing.com
Arcus Biosciences chief accounting officer sells $66,023 in stock By Investing.com
Arcus Biosciences chief accounting officer sells $66,023 in stock By Investing.com
Arcus Biosciences chief accounting officer sells $66,023 in stock
Arcus Biosciences (RCUS) CAO 10b5-1 sale of 2,562 shares
[144] Arcus Biosciences, Inc. SEC Filing
¿Qué ejecutivos compran y venden acciones de Arcus Biosciences? Vea la última actividad de uso de información privilegiada de RCUS en MarketBeat.
RCUS Stock Price, Quote & Chart | ARCUS BIOSCIENCES INC (NYSE:RCUS)
Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Arcus Biosciences joins Goldman Sachs chat, offers live webcast June 9
Sólo acción del precio: los movimientos de Arcus Biosciences Inc. (RCUS) marcan la pauta para los modelos institucionales. Mapeo de liquidez en torno a eventos de precios (RCUS)
RCUS Assumes Buy by Truist Securities -- Price Target Raised to $35
RCUS Assumes Buy by Truist Securities -- Price Target Raised to $35
RCUS Assumes Buy by Truist Securities -- Price Target Raised to $35
Página 2 de 11
